Lance A Smith Selected Research

Lance A Smith Research Topics

13	Dyskinesias (Dyskinesia) 02/2014 - 09/2002
10	Parkinson Disease (Parkinson's Disease) 01/2010 - 09/2002
2	Chorea (Rheumatic Chorea) 10/2003 - 09/2002
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2006
1	Multiple System Atrophy 11/2006
1	Dystonia (Limb Dystonia) 10/2003
1	Hyperkinesis 09/2002

14	Levodopa (L Dopa)FDA LinkGeneric 02/2014 - 09/2002
13	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2014 - 09/2002
5	Dopamine (Intropin)FDA LinkGeneric 01/2010 - 09/2002
4	Dopamine Agonists (Dopamine Agonist)IBA 12/2007 - 09/2002
3	Dopamine Receptors (Dopamine Receptor)IBA 01/2010 - 09/2002
3	entacapone (Comtan)FDA Link 12/2007 - 05/2003
2	Proteins (Proteins, Gene)FDA Link 02/2014 - 11/2006
2	Carbidopa (Lodosyn)FDA LinkGeneric 01/2010 - 03/2005
2	ropinirole (Requip)FDA LinkGeneric 12/2007 - 03/2007
2	Piribedil (Trivastal)IBA 05/2006 - 09/2002
2	PiperazineIBA 09/2002 - 09/2002
1	Peptides (Polypeptides)IBA 02/2014
1	catechol (pyrocatechol)IBA 12/2007
1	BenserazideIBA 04/2007
1	NeuropeptidesIBA 04/2007
1	glycine amideIBA 04/2007
1	OsteopontinIBA 11/2006
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 09/2006
1	2- n- butyl- 9- methyl- 8- (1,2,3)triazol- 2- yl- 9H- purin- 6- ylamineIBA 09/2006
1	BTS 74 398IBA 01/2004
1	Pramipexole (Mirapex)FDA LinkGeneric 10/2003
1	Serotonin (5 Hydroxytryptamine)IBA 10/2003
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 10/2003
1	vanoxerine (I 893)IBA 09/2002
1	brasofensineIBA 09/2002
1	Dopamine Agents (Dopaminergic Agents)IBA 09/2002

2	Therapeutics 01/2010 - 12/2007
1	Oral Administration 05/2006